Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations

Objectives: The rapid fatality of pancreatic cancer is, in large part, the result of diagnosis at an advanced stage in the majority of patients. Identification of individuals at risk of developing pancreatic adenocarcinoma would be useful to improve the prognosis of this disease. There is presently no biological or genetic indicator allowing the detection of patients at risk. Our main goal was to identify copy number variants (CNVs) common to all patients with sporadic pancreatic cancer. Methods: We analyzed gene CNVs in leukocyte DNA from 31 patients with sporadic pancreatic adenocarcinoma and from 93 matched controls. Genotyping was performed with the use of the GeneChip Human Mapping 500K Array Set (Affymetrix). Results: We identified 431 single nucleotide polymorphism (SNP) probes with abnormal hybridization signal present in the DNA of all 31 patients. Of these SNP probes, 284 corresponded to 3 or more copies and 147 corresponded to 1 or 0 copies. Several cancer-associated genes were amplified in all patients. Conversely, several genes supposed to oppose cancer development were present as single copy. Conclusions: These data suggest that a set of 431 CNVs could be associated with the disease. This set could be useful for early diagnosis.

[1]  S. Batra,et al.  Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis. , 2012, Carcinogenesis.

[2]  Yu-hong Li,et al.  Are Risk Factors Associated with Outcomes in Pancreatic Cancer? , 2012, PloS one.

[3]  S. Wild,et al.  Copy Number Variation across European Populations , 2011, PloS one.

[4]  Tomas W. Fitzgerald,et al.  Origins and functional impact of copy number variation in the human genome , 2010, Nature.

[5]  Geoffrey S. Tobias,et al.  Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer , 2009, Nature Genetics.

[6]  Yong-shu He,et al.  [Structural variation in the human genome]. , 2009, Yi chuan = Hereditas.

[7]  E. Cook,et al.  Population-specific GSTM1 copy number variation. , 2009, Human molecular genetics.

[8]  Allen D. Delaney,et al.  Impact of whole genome amplification on analysis of copy number variants , 2008, Nucleic acids research.

[9]  Jan Komorowski,et al.  Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. , 2008, American journal of human genetics.

[10]  J. Sebat,et al.  Copy-number variants in patients with a strong family history of pancreatic cancer , 2007, Cancer biology & therapy.

[11]  S. Larsson,et al.  Body mass index and pancreatic cancer risk: A meta‐analysis of prospective studies , 2007, International journal of cancer.

[12]  D. Conrad,et al.  Global variation in copy number in the human genome , 2006, Nature.

[13]  Andrew J Lees,et al.  Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability , 2006, Nature Genetics.

[14]  R. Pfundt,et al.  A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism , 2006, Nature Genetics.

[15]  R. Redon,et al.  Copy number variation: new insights in genome diversity. , 2006, Genome research.

[16]  R Redon,et al.  Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders , 2006, Journal of Medical Genetics.

[17]  L. Feuk,et al.  Detection of large-scale variation in the human genome , 2004, Nature Genetics.

[18]  P. Ruszniewski,et al.  Risk of pancreatic adenocarcinoma in chronic pancreatitis , 2002, Gut.

[19]  P. Chappuis,et al.  The Role of Genetic Factors in the Etiology of Pancreatic Adenocarcinoma: An Update , 2001, Cancer investigation.

[20]  S. Goodman,et al.  Very high risk of cancer in familial Peutz-Jeghers syndrome. , 2000, Gastroenterology.

[21]  S. Gallinger,et al.  Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. , 2000, Cancer research.

[22]  A M Goldstein,et al.  Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. , 1995, The New England journal of medicine.

[23]  E. Diamandis,et al.  Pancreatic cancer. , 2013, Clinical chemistry.

[24]  Wen Tan,et al.  Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk. , 2012, Carcinogenesis.

[25]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[26]  M. de Andrade,et al.  Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. , 2008, Gastroenterology.

[27]  R. DePinho,et al.  Genetics and biology of pancreatic ductal adenocarcinoma , 2006, Genes & development.

[28]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.